Investigative Ophthalmology & Visual Science Cover Image for Volume 63, Issue 7
June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Changes in visual function in eyes with myopic traction maculopathy over 1 year
Author Affiliations & Notes
  • Qiu Ying Wong
    Singapore Eye Research Institute, Singapore
  • Yee Shan Dan
    Singapore Eye Research Institute, Singapore
  • Chloe S.Q. Chua
    Singapore Eye Research Institute, Singapore
  • Marcus Ang
    Singapore Eye Research Institute, Singapore
  • Quan V Hoang
    Singapore Eye Research Institute, Singapore
    Ophthalmology, Columbia University, New York, New York, United States
  • Chee Wai Wong
    Singapore Eye Research Institute, Singapore
  • Footnotes
    Commercial Relationships   Qiu Ying Wong None; Yee Shan Dan None; Chloe Chua None; Marcus Ang None; Quan Hoang None; Chee Wai Wong None
  • Footnotes
    Support  Industry Alignment Fund - Industry Collaboration Projects (IAF-ICP) Grant (I1901E0038) and Johnson & Johnson Vision
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 405. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Qiu Ying Wong, Yee Shan Dan, Chloe S.Q. Chua, Marcus Ang, Quan V Hoang, Chee Wai Wong; Changes in visual function in eyes with myopic traction maculopathy over 1 year. Invest. Ophthalmol. Vis. Sci. 2022;63(7):405.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To assess the longitudinal change in macular thickness and visual function in highly myopic eyes with and without myopic traction maculopathy (MTM).

Methods : 109 eyes of 65 highly myopic patients were enrolled from the Myopic and Pathologic Eyes in Singapore (MyoPES) cohort and followed for at least 12 months. Axial length (AL) and logMAR best-corrected visual acuity (BCVA) were measured. Swept-source optical coherence tomography (SS-OCT) was performed, and images were evaluated for MTM and central subfield retinal thickness (CRT). Macular sensitivity (MS) was measured with MP-3 microperimetry.

Results : At baseline, mean age was 57.5±13.5 years and mean AL was 29.3±2.7mm and 20 eyes (18.4%) had MTM. On average, compared to eyes without MTM, eyes with MTM had significantly longer AL (30.8±1.7mm vs. 29.1±2.8mm, p=0.01), greater CRT (319±74um vs. 242±42um, p<0.001) and lower MS (19.8±4.1dB vs. 22.6±5.3dB, p=0.03). BCVA did not differ (0.33±0.39 vs. 0.24±0.29, p=0.22). At 1 year, MTM progressed in 5 eyes (25%) and resolved in 1 eye (5%). In eyes with progression, CRT increased from 302±57um to 359±83um (p=0.14). MS at 1 year in eyes with (20.2±4.1dB) and without MTM (21.8±5.5dB) did not significantly differ from baseline values (p=0.60 and 0.16, respectively).

Conclusions : Although visual acuity did not differ, visual function as measured by microperimetry was significantly worse in highly myopic eyes with MTM than those without at baseline. Over the span of 1 year, no significant change in macular sensitivity was observed in eyes despite MTM progression.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×